News

Intensive Follow-Up Reduces Mortality From Hepatocellular Cancer

Publish date: May 7, 2012

 

FROM A SYMPOSIUM SPONSORED BY THE SOCIETY OF SURGICAL ONCOLOGY

In contrast, early recurrences generally respond to repeat resection, salvage transplantation, radiofrequency ablation, or transarterial chemoembolization, Dr. Pawlik noted.

Dr. Pawlik said he has no relevant disclosures.

Pages

Recommended Reading

Liver Cancer Predictors in Chronic Hepatitis B Identified
MDedge Internal Medicine
Use of Ultrasound Expands Across Surgical Specialties
MDedge Internal Medicine
Acetaminophen Safe in Alcoholics, Analysis Suggests
MDedge Internal Medicine
Underlying Health Conditions May Boost C. difficile Risk in Kids
MDedge Internal Medicine
Abatacept May Aid RA Patients With Hepatitis B
MDedge Internal Medicine
Duodenal GIST Responds to Surgery, Imatinib
MDedge Internal Medicine
Fecal Transplant Tackles C. diff; Linezolid Good for MRSA Pneumonia
MDedge Internal Medicine
Wide Disparity in Appendicitis Costs Observed
MDedge Internal Medicine
Variceal Rebleeding Twice as Likely If Beta-Blockers Fail
MDedge Internal Medicine
Infliximab Called 'Optimal' for Refractory Ulcerative Colitis
MDedge Internal Medicine